Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 05, 2007. The document serves as a notification of transactions involving a Person Discharging Managerial Responsibility, specifically Dr. R G Greig, in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction and does not contain general financial performance data.
Material Changes
The filing details a specific transaction on December 05, 2007, involving Dr. R G Greig:
- Option Exercise: Exercise of options over 12,500 American Depositary Shares (ADSs) granted on December 15, 2003, at a price of $44.57 per ADS.
- Share Sale: Immediate sale of the 12,500 ADSs at a price of $52.70 per ADS.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the disclosed insider transaction.
Investor Verification Checklist
- Verify the total number of ADSs held by Dr. R G Greig following this transaction.
- Confirm the current status of the GlaxoSmithKline Share Option Plan referenced in the grant date of December 15, 2003.
- Review the company's broader insider trading activity for the same period to assess overall executive sentiment.